Omega Diagnostics (RVKA) Financial Statements

0 Followers

Omega Diagnostics Financial Overview

Omega Diagnostics's market cap is currently €3.87M. The company's EPS TTM is €-0.0228; its P/E ratio is -0.57; Omega Diagnostics is scheduled to report earnings on September 8, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Income Statement
Total Revenue	£ 6.97M	£ 8.33M	£ 9.77M	£ 7.55M	£ 8.54M
Gross Profit	£ 4.28M	£ 5.00M	£ 6.05M	£ 3.17M	£ 4.75M
Operating Income	£ -1.04M	£ -640.00K	£ -535.00K	£ -2.78M	£ -582.00K
EBITDA	£ -392.00K	£ 2.20M	£ -73.00K	£ -2.65M	£ -382.00K
Net Income	£ -5.83M	£ 1.57M	£ -328.00K	£ -3.86M	£ -11.33M
Balance Sheet
Cash & Short-Term Investments	£ 2.64M	£ 4.87M	£ 5.44M	£ 5.12M	£ 1.60M
Total Assets	£ 7.45M	£ 13.80M	£ 13.89M	£ 14.40M	£ 17.84M
Total Debt	£ 125.00K	£ 349.00K	£ 148.00K	£ 74.00K	£ 370.00K
Net Debt	£ -2.51M	£ -4.52M	£ -2.79M	£ -5.04M	£ -1.24M
Total Liabilities	£ 1.77M	£ 2.39M	£ 4.21M	£ 4.45M	£ 6.02M
Stockholders' Equity	£ 5.68M	£ 11.41M	£ 9.68M	£ 9.95M	£ 11.82M
Cash Flow
Free Cash Flow	£ -1.39M	£ -142.00K	£ 548.00K	£ -3.31M	£ -4.71M
Operating Cash Flow	£ -1.13M	£ 83.00K	£ 607.00K	£ -3.15M	£ -3.23M
Investing Cash Flow	£ -810.00K	£ 2.12M	£ -2.51M	£ 5.18M	£ -493.00K
Financing Cash Flow	£ -232.00K	£ -251.00K	£ -265.00K	£ 1.49M	£ -502.00K

Currency in GBP

Omega Diagnostics Earnings and Revenue History

Income Statement >

Omega Diagnostics Debt to Assets

Balance Sheet >

Omega Diagnostics Cash Flow

Cash Flow >

Omega Diagnostics Forecast EPS vs Actual EPS

Earnings >